These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 898120)

  • 21. [The effect of xanthinol nicotinate on the serum lipids and lipoproteins of patients with primary hyperlipoproteinemia Type IIb and IV].
    Haacke H; Parwaresch MR; Mäder C
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():829-32. PubMed ID: 1029294
    [No Abstract]   [Full Text] [Related]  

  • 22. [Complamin in the complex therapy of patients with chronic nonspecific prostatitis].
    Iunda IF; Israilov SR
    Vrach Delo; 1987 Nov; (11):64-7. PubMed ID: 3439130
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of sudden deafness with increasing doses of sadamine].
    Betkowski A; Cyran-Rymarz A; Gośniak-Kurek E; Kuzniar W; Smolik B; Wysocka-Kuźniar S
    Wiad Lek; 1981 Jul; 34(14):1165-74. PubMed ID: 7331319
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rehabilitation course in patients with peripheral and coronary angio-organopathies. Studies with special reference to serum uric acid and cholesterol under xanthinol nicotinate].
    Mensen H
    Ther Ggw; 1977 Oct; 116(10):1853-81. PubMed ID: 918880
    [No Abstract]   [Full Text] [Related]  

  • 25. Xantinol nicotinate in paralytic poliomyelitis.
    Saksena PN; Malik GK; Tandon OP
    Indian Pediatr; 1979 Dec; 16(12):1081-4. PubMed ID: 541073
    [No Abstract]   [Full Text] [Related]  

  • 26. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
    Raspanti D; Cameli AM; Trapani M; Dorigo D; Mazzotta A; Negro P
    Clin Ter; 1987 Jun; 121(6):479-83. PubMed ID: 2973884
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of hyperlipidemia with xanthinol nicotinate as opposed to low fat diet].
    Baumann J; Martschick R
    Med Welt; 1982 Jan; 33(4):139-41. PubMed ID: 7062844
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon.
    Szilvási I; Molnár G
    Ther Hung; 1973; 21(3-4):114-6. PubMed ID: 4806418
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
    Kalmykova VI; Aronchuk EK
    Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical trials of angioxine].
    Morgon A
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Feb; 24(2):162. PubMed ID: 123948
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of the efficacy of xavin treatment of ischemic heart disease].
    Pomerantsev VP; Ivanova NA; Zadionchenko VS; Vertkin AL; Martynov AI
    Kardiologiia; 1978 Mar; 18(3):36-43. PubMed ID: 347136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of teonikol in bronchial asthma in children].
    Geppe NA; Sokolovskiĭ GA; Akhmatalieva MA
    Pediatriia; 1986 Dec; (12):52-3. PubMed ID: 3822709
    [No Abstract]   [Full Text] [Related]  

  • 33. [The observation of the influence of the unretarded form of xanthinol-niacinate (Complamine) in ulcus cruris venosum on the skin temperature of the lower extremities with the biochemical determination of the levels of the preparation (author's transl)].
    Resl V; Götzová ; Vitous J
    Cesk Dermatol; 1976 Dec; 51(6):389-93. PubMed ID: 1009598
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of therapeutic agents on acute ocular toxicity of methyl alcohol (an experimental study).
    Khosla PK; Gupta AK; Tewari HK
    Indian J Ophthalmol; 1983 Sep; 31(5):535-7. PubMed ID: 6671751
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G; Majorana M
    Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
    [No Abstract]   [Full Text] [Related]  

  • 36. [Xanthinic derivatives in the treatment of intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D; Rojas Hidalgo E
    Rev Clin Esp; 1986 Jul; 179(3):162. PubMed ID: 3764000
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacological properties and clinical use of xanthinol nicotinate].
    Mashkovskiĭ MD; Iuzhakov SD; Absava GI; Erokhina LG; Lebedeva NV
    Klin Med (Mosk); 1984 Nov; 62(11):30-4. PubMed ID: 6097742
    [No Abstract]   [Full Text] [Related]  

  • 38. [Assessment of the action of Sadamine Polfa and Mydocalm Richter preparations as based on photoplethysmography].
    Chwistecki K; Bochenek W; Lawiński M
    Pol Tyg Lek; 1975 Dec; 30(50):2093-6. PubMed ID: 1197101
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prolonged clinical study of the LA, 313-B-xanthinol niacinate pentosan sulfonate ester combination in various forms of hypertension].
    Masso M; Gimeno Martínez J; Honorato J
    Rev Clin Esp; 1976 Jul; 142(2):157-61. PubMed ID: 968103
    [No Abstract]   [Full Text] [Related]  

  • 40. [Teonicol and trental in the treatment of duodenal ulcer].
    Vorob'ev LP; Samsonov AA; Pivovarova EIa
    Sov Med; 1986; (10):98-100. PubMed ID: 3544244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.